Initial Evaluation of Ferumoxytol as a Renal-Safe MR Contrast Agent for Abdominal Vascular Assessment

Keywords

abdominal abnormalities absence administered agent agents although analyzed aneurysm angiography aortic apparent approved arrow arrows arterial artery artifact artifacts assessment audience available aware beginning benign black blood blue board body boluses branches breath carcinoma central cerebral certain characteristics chaser clinical complete concentration concentrations confirmation confirmed confirming consensus contrast criteria demonstrating described descriptions despite detect disease dissection distal divisional duke dynamic early elucidate enhancement equilibrium evaluated evaluating experience findings flow gadolinium help hepatic identified included index influenced initial injected injection institutional intravenous involved iron known label lack least local malignant mass material medical mimicking modality notably note oxide patient patients pharmaceuticals pitfalls pool portal portion post practice predictive preliminary presence previously protocol proven proximal radiologists radiology receive reduce related relatively renal retrospective review safe saline segment sets shortening since stage statistically studies suggest suggests suitable susceptibility systems target thromboses thrombosis tumor unpaired useful utility vascular vein veins venous vessel visualized void white